Correlation Between Dupont De and Pharmadrug

Can any of the company-specific risk be diversified away by investing in both Dupont De and Pharmadrug at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Pharmadrug into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dupont De Nemours and Pharmadrug, you can compare the effects of market volatilities on Dupont De and Pharmadrug and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Pharmadrug. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Pharmadrug.

Diversification Opportunities for Dupont De and Pharmadrug

0.28

Correlation Coefficient

Dupont De  Pharmadrug

Modest diversification

The 3 months correlation between Dupont and Pharmadrug is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Pharmadrug in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmadrug and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Pharmadrug. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmadrug has no effect on the direction of Dupont De i.e., Dupont De and Pharmadrug go up and down completely randomly.

Pair Corralation between Dupont De and Pharmadrug

Allowing for the 90-day total investment horizon Dupont De Nemours is expected to under-perform the Pharmadrug. But the stock apears to be less risky and, when comparing its historical volatility, Dupont De Nemours is 10.27 times less risky than Pharmadrug. The stock trades about -0.01 of its potential returns per unit of risk. The Pharmadrug is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  0.95  in Pharmadrug on December 29, 2024 and sell it today you would lose (0.13) from holding Pharmadrug or give up 13.68% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	96.72%
Values	Daily Returns

Dupont De Nemours  vs.  Pharmadrug

Dupont De Nemours

Risk-Adjusted Performance

Very Weak

Over the last 90 days Dupont De Nemours has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Dupont De is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pharmadrug

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Pharmadrug are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile essential indicators, Pharmadrug reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Dupont De and Pharmadrug

The main advantage of trading using opposite Dupont De and Pharmadrug positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Pharmadrug can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmadrug will offset losses from the drop in Pharmadrug's long position.

The idea behind Dupont De Nemours and Pharmadrug pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.